Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#321 of 589

Swayampakula Ramakanth

HC Wainwright & Co. · Equity Research Analyst
EstablishedRating since 2019No new ratings since Nov 2025

Analyst rating accuracy & track record

Swayampakula Ramakanth is an equity research analyst at HC Wainwright & Co.. Quantellect has scored 275 of their stock calls across 45 companies. Their picks beat their sector 38% of the time over the next 12 months, and their price targets were reached 25% of the time within a year.

Win % vs sector
38%
PT Hit % (12mo)
25%
Avg sector-excess
−6.2%
Scored calls
275
Tickers
45
Tier
Established

Track record

Quantellect has scored 275 of Swayampakula Ramakanth's stock calls across 45 companies, dating back to 2019. Their rated stocks beat their own sector 38% of the time over the next 12 months. On a typical call, a Ramakanth pick returned −6.2% more than its sector over the following year.

Of the scored calls, 275 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
INTSIntensity Therapeutics, Inc. Common stock
Buy$125.00Nov 2025−98.1%Miss
PSNLPersonalis Inc
Buy$13.00Nov 2025+74.6%Hit
DNTHDianthus Therapeutics Inc.
Buy$47.00Nov 2025+119.6%Hit
XFORX4 Pharmaceuticals Inc
Buy$5.00Nov 2025−34.5%Miss
XFORX4 Pharmaceuticals Inc
Buy$5.00Nov 2025−34.5%Miss
PSNLPersonalis Inc
Buy$10.00Nov 2025+100.3%Hit
BCYCBicycle Therapeutics Ltd
Buy$33.00Oct 2025−79.0%Miss
IPHAInnate Pharma
Buy$5.00Oct 2025−53.2%Miss
UNCYUnicycive Therapeutics Inc
Buy$22.00Oct 2025−49.4%Miss
VORVor Biopharma Inc
Buy$52.00Oct 2025−45.0%Miss
DYAIDyadic International Inc
Buy$3.00Oct 2025−88.7%Miss
CELCCelcuity LLC
Buy$77.00Oct 2025−32.3%Hit
CORTCorcept Therapeutics Incorporated
Buy$145.00Oct 2025+29.5%Miss
DCTHDelcath Systems Inc
Buy$30.00Oct 2025+4.7%Miss
CORTCorcept Therapeutics Incorporated
Buy$145.00Oct 2025+47.2%Miss
ACTUActuate Therapeutics, Inc. Common stock
Buy$20.00Sep 2025−114.4%Miss
PSNLPersonalis Inc
Buy$8.50Sep 2025+185.8%Hit
DNTHDianthus Therapeutics Inc.
Buy$40.00Sep 2025+184.6%Hit
CLGNCollplant Biotechnologies Ltd
Buy$11.00Aug 2025−115.6%Miss
CLGNCollplant Biotechnologies Ltd
Buy$11.00Aug 2025−115.6%Miss
PYXSPyxis Oncology Inc
Buy$5.00Aug 2025+161.1%Hit
PGENPrecigen Inc
Buy$8.50Aug 2025+93.6%Miss
CELCCelcuity LLC
Buy$66.00Aug 2025+63.7%Hit
ACTUActuate Therapeutics, Inc. Common stock
Buy$20.00Aug 2025−112.5%Miss
PGENPrecigen Inc
Buy$8.50Aug 2025+97.5%Miss
Prev1…
Go to

Swayampakula Ramakanth: analyst track record FAQ

Is Swayampakula Ramakanth a good stock analyst?

Yes, by track record. Swayampakula Ramakanth ranks number 321 of 589 of the analysts Quantellect scores, with an Analyst Score of 31 out of 100. Past results do not guarantee future ones.

What is Swayampakula Ramakanth's win rate?

Swayampakula Ramakanth's win rate is 38%. Across 275 scored calls, their rated stocks beat their sector 38% of the time over the next 12 months. On a typical call they returned −6.2% more than the sector.

What stocks and sectors does Swayampakula Ramakanth cover?

Swayampakula Ramakanth covers 45 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Swayampakula Ramakanth's price targets accurate?

Swayampakula Ramakanth's price targets are reached within 12 months 25% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Swayampakula Ramakanth's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Swayampakula Ramakanth rank among Wall Street analysts?

Swayampakula Ramakanth ranks number 321 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.